mPharma Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
507
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
35
mPharma General Information
Description
Developer of a pharmaceutical data analytics platform designed to make prescription drugs accessible and affordable in emerging markets. The company's platform manages prescription drug inventory for pharmacies and their suppliers and helps them to prescribe and locate the medicines they need and report adverse drug reactions, enabling pharmacies to guarantee the medicines that are needed are always available and affordable.
Contact Information
Website
www.mpharma.comCorporate Office
- 13, Moon Flower Close
- East Legon, Accra
- Ghana
Corporate Office
- 13, Moon Flower Close
- East Legon, Accra
- Ghana
mPharma Timeline
mPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Accelerator/Incubator | 30-Apr-2025 | Completed | Generating Revenue | |||
| 14. Later Stage VC | 30-Jan-2024 | Completed | Generating Revenue | |||
| 13. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 12. Later Stage VC (Series D) | 04-Mar-2022 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 10. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 10-Apr-2020 | Completed | Generating Revenue | |||
| 8. Grant | 15-Apr-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 10-Jan-2019 | $9.7M | $22.2M | Completed | Generating Revenue | |
| 6. Early Stage VC (Series A) | 24-Nov-2017 | $6.6M | $12.5M | Completed | Generating Revenue |
mPharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | ||||||||
| Seed 2 | 8,198,837 | $0.000100 | $0.63 | $0.63 | 1x | $0.63 | 18.55% | |
| Seed 1 | 1,720,774 | $0.000100 | $0.34 | $0.34 | 1x | $0.34 | 3.89% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
mPharma Comparisons
Industry
Financing
Details
mPharma Competitors (4)
One of mPharma’s 4 competitors is Sempre Health, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sempre Health | Venture Capital-Backed | San Francisco, CA | ||||
| GoodRx | Formerly PE-Backed | Santa Monica, CA | ||||
| Global Healthcare Exchange | Private Equity-Backed | Louisville, CO | ||||
| Medplus (Nigeria) | Private Equity-Backed | Lagos, Nigeria |
mPharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
mPharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
mPharma Investors (35)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Investing in Innovation | Accelerator/Incubator | |||
| Angel (individual) | Minority | |||
| Alarko Ventures | Corporate Venture Capital | Minority | ||
| Caravelle Investment | Growth/Expansion | Minority | ||
| Citigroup | Investment Bank | Minority |
mPharma Acquisitions (3)
mPharma’s most recent deal was a Merger/Acquisition with HealthPlus Nigeria. The deal was made on 15-Sep-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| HealthPlus Nigeria | 15-Sep-2022 | Merger/Acquisition | Specialty Retail | ||
| Vine Pharmaceuticals | 27-Oct-2021 | Merger/Acquisition | Specialty Retail | ||
| Haltons Pharmacy | 28-May-2019 | Merger/Acquisition | Other Healthcare Services |
mPharma Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Haltons Pharmacy | Nairobi, Kenya | 2013 | |
| HealthPlus Nigeria | Lagos, Nigeria | 1999 |
mPharma FAQs
-
When was mPharma founded?
mPharma was founded in 2013.
-
Where is mPharma headquartered?
mPharma is headquartered in East Legon, Ghana.
-
What is the size of mPharma?
mPharma has 507 total employees.
-
What industry is mPharma in?
mPharma’s primary industry is Enterprise Systems (Healthcare).
-
Is mPharma a private or public company?
mPharma is a Private company.
-
What is mPharma’s current revenue?
The current revenue for mPharma is .
-
How much funding has mPharma raised over time?
mPharma has raised $89.4M.
-
Who are mPharma’s investors?
Investing in Innovation, , Alarko Ventures, Caravelle Investment, and Citigroup are 5 of 35 investors who have invested in mPharma.
-
Who are mPharma’s competitors?
Sempre Health, GoodRx, Global Healthcare Exchange, and Medplus (Nigeria) are competitors of mPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
